skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Refined by: Database: Coronavirus Research Database remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Material Type:
Article 		Add to My Research

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Cell, 2020-05, Vol.181 (4), p.865-876.e12 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.04.020 ;PMID: 32353252

Digital Resources/Online E-Resources

Citations Cited by
2
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
Material Type:
Article 		Add to My Research

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Nature communications, 2022-05, Vol.13 (1), p.2766-16, Article 2766 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-30546-7 ;PMID: 35589813

Full text available

Citations Cited by
3
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza
Material Type:
Article 		Add to My Research

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

bioRxiv, 2020-03

2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2020.03.13.991307v1 ;DOI: 10.1101/2020.03.13.991307

Digital Resources/Online E-Resources

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2)
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait